OmniComm Systems, Inc., a provider of integrated electronic data capture (EDC) solutions for clinical trials, has been selected by Amarex, a
Mid-Atlantic based Contract Research Organization (CRO), to provide the company with eClinical solutions for an upcoming Phase III trial.
The trial will be investigating the use of a medical device for wound healing. The study will be conducted at over 30 sites and will recruit up to 300 patients over the course of two years.
Amarex also joins OmniComm’s CRO Preferred Program, which will allow them to offer OmniComm’s electronic data capture solution, TrialMaster, to their clients.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.